SCHEMBL3343751

SCHEMBL3343751

Cc1ccc(-c2nnn(C)n2)cc1C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WNT1 P04628 1/20 0.39
GSK3B P49841 1/20 0.39
DYRK1A Q13627 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
SIRT3 Q9NTG7 1/20 0.37
ENPP3 O14638 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
RAB9A P51151 3/20 0.37
BRD4 O60885 1/20 0.37
BRD9 Q9H8M2 1/20 0.37
TP53 P04637 1/20 0.37
LMNA P02545 4/20 0.36
POLB P06746 2/20 0.36
PDE4D Q08499 1/20 0.36
PDE7A Q13946 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
SYK P43405 1/20 0.36
NPC1 O15118 2/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927936 0.79 MKNK1 (0.44) SMN1; SMN2RAB9ABRD4BRD9TP53
SCHEMBL27430479 0.78 HRH4 (0.42) WNT1GSK3BDYRK1ASMN1; SMN2RAB9A
SCHEMBL2476613 0.77 TSHR (0.43) WNT1GSK3BDYRK1ASMN1; SMN2TP53
SCHEMBL3343755 0.77 RAB9A (0.44) TDP1SMN1; SMN2RAB9ALMNANPC1
SCHEMBL3346118 0.77 SYK (0.40) DYRK1ATDP1SIRT3ENPP3RAB9A
SCHEMBL30967607 0.77 NPC1 (0.47) SMN1; SMN2RAB9ABRD4LMNAPDE4D
SCHEMBL3348705 0.75 SMN1; SMN2 (0.44) WNT1GSK3BDYRK1ATDP1SIRT3
SCHEMBL3342287 0.74 MKNK2 (0.47) TDP1SIRT3ENPP3SMN1; SMN2RAB9A
SCHEMBL6609423 0.74 TRPV1 (0.42) WNT1GSK3BDYRK1ATDP1SMN1; SMN2
SCHEMBL3346669 0.74 MKNK1 (0.53) DYRK1ATDP1SIRT3MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 WNT1 3548/4885GSK3B 3653/4885DYRK1A 1152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.